7,837
Views
0
CrossRef citations to date
0
Altmetric
Review

Methods In Dna Methylation Profiling

, , , &
Pages 331-345 | Published online: 03 Dec 2009

Bibliography

  • Waddinton C : The epigenotype.Endeavor1 , 18–24 (1942).
  • Antequera F : Structure, function and evolution of CpG island promoters.Cell. Mol. Life Sci.60(8) , 1647–1658 (2003).
  • Illingworth R , KerrA, DesousaD et al.: A novel CpG island set identifies tissue-specific methylation at developmental gene loci.PLoS Biol.6(1) , E22 (2008).
  • Suzuki MM , BirdA: DNA methylation landscapes: provocative insights from epigenomics.Nat. Rev. Genet.9(6) , 465–476 (2008).
  • Rollins RA , HaghighiF, EdwardsJR et al.: Large-scale structure of genomic methylation patterns.Genome Res.16(2) , 157–163 (2006).
  • Klose RJ , BirdAP: Genomic DNA methylation: the mark and its mediators.Trends Biochem. Sci.31(2) , 89–97 (2006).
  • Goll MG , BestorTH: Eukaryotic cytosine methyltransferases.Annu. Rev. Biochem.74 , 481–514 (2005).
  • Leonhardt H , PageAW, WeierHU, BestorTH: A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei.Cell71(5) , 865–873 (1992).
  • Kangaspeska S , StrideB, MetivierR et al.: Transient cyclical methylation of promoter DNA.Nature452(7183) , 112–115 (2008).
  • Metivier R , GallaisR, TiffocheC et al.: Cyclical DNA methylation of a transcriptionally active promoter.Nature452(7183) , 45–50 (2008).
  • Rai K , HugginsIJ, JamesSR, KarpfAR, JonesDA, CairnsBR: DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45.Cell135(7) , 1201–1212 (2008).
  • Ooi SK , BestorTH: The colorful history of active DNA demethylation.Cell133(7) , 1145–1148 (2008).
  • Jones PA , BaylinSB: The fundamental role of epigenetic events in cancer.Nat. Rev. Genet.3(6) , 415–428 (2002).
  • Feinberg AP , TyckoB: The history of cancer epigenetics.Nat. Rev. Cancer4(2) , 143–153 (2004).
  • Jones PA , BaylinSB: The epigenomics of cancer.Cell128(4) , 683–692 (2007).
  • Esteller M : Epigenetics in cancer.N. Engl. J. Med.358(11) , 1148–1159 (2008).
  • Ushijima T , SasakoM: Focus on gastric cancer.Cancer Cell5(2) , 121–125 (2004).
  • Gaudet F , HodgsonJG, EdenA et al.: Induction of tumors in mice by genomic hypomethylation.Science300(5618) , 489–492 (2003).
  • Yoo CB , JonesPA: Epigenetic therapy of cancer: past, present and future.Nat. Rev. Drug Discov.5(1) , 37–50 (2006).
  • Bibikova M , LaurentLC, RenB, LoringJF, FanJB: Unraveling epigenetic regulation in embryonic stem cells.Cell Stem Cell2(2) , 123–134 (2008).
  • Plass C : Cancer epigenomics.Hum. Mol. Genet.11(20) , 2479–2488 (2002).
  • Huang TH , PerryMR, LauxDE: Methylation profiling of CpG islands in human breast cancer cells.Hum. Mol. Genet.8(3) , 459–470 (1999).
  • Heisler LE , TortiD, BoutrosPC et al.: CpG island microarray probe sequences derived from a physical library are representative of CpG islands annotated on the human genome.Nucleic Acids Res.33(9) , 2952–2961 (2005).
  • Weber M , DaviesJJ, WittigD et al.: Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells.Nat. Genet.37(8) , 853–862 (2005).
  • Ching TT , MaunakeaAK, JunP et al.: Epigenome analyses using bac microarrays identify evolutionary conservation of tissue-specific methylation of shank3.Nat. Genet.37(6) , 645–651 (2005).
  • Cowell JK , HawthornL: The application of microarray technology to the analysis of the cancer genome.Curr. Mol. Med.7(1) , 103–120 (2007).
  • Ishkanian AS , MalloffCA, WatsonSK et al.: A tiling resolution DNA microarray with complete coverage of the human genome.Nat. Genet.36(3) , 299–303 (2004).
  • Lippman Z , GendrelAV, ColotV, MartienssenR: Profiling DNA methylation patterns using genomic tiling microarrays.Nat. Methods2(3) , 219–224 (2005).
  • Rauch TA , ZhongX, WuX et al.: High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.Proc. Natl Acad. Sci. USA105(1) , 252–257 (2008).
  • Hayashi H , NagaeG, TsutsumiS et al.: High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array.Hum. Genet.120(5) , 701–711 (2007).
  • Schumacher A , KapranovP, KaminskyZ et al.: Microarray-based DNA methylation profiling: technology and applications.Nucleic Acids Res.34(2) , 528–542 (2006).
  • Yan PS , ChenCM, ShiH et al.: Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.Cancer Res.61(23) , 8375–8380 (2001).
  • Yan PS , ChenCM, ShiH, RahmatpanahF, WeiSH, HuangTH: Applications of CpG island microarrays for high-throughput analysis of DNA methylation.J. Nutr.132(8 Suppl.) , S2430–S2434 (2002).
  • Wei SH , ChenCM, StrathdeeG et al.: Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.Clin.Cancer Res.8(7) , 2246–2252 (2002).
  • Hatada I , FukasawaM, KimuraM et al.: Genome-wide profiling of promoter methylation in human.Oncogene25(21) , 3059–3064 (2006).
  • Fukasawa M , KimuraM, MoritaS et al.: Microarray analysis of promoter methylation in lung cancers.J. Hum. Genet.51(4) , 368–374 (2006).
  • Khulan B , ThompsonRF, YeK et al.: Comparative isoschizomer profiling of cytosine methylation: the help assay.Genome Res.16(8) , 1046–1055 (2006).
  • Nouzova M , HoltanN, OshiroMM et al.: Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.J. Pharmacol. Exp. Ther.311(3) , 968–981 (2004).
  • Irizarry RA , Ladd-AcostaC, CarvalhoB et al.: Comprehensive high-throughput arrays for relative methylation (CHARM).Genome Res.18(5) , 780–790 (2008).
  • Irizarry RA , Ladd-AcostaC, WenB et al.: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.Nat. Genet.41(2) , 178–186 (2009).
  • Stirzaker C , SongJZ, DavidsonB, ClarkSJ: Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.Cancer Res.64(11) , 3871–3877 (2004).
  • Wang Y , YuQ, ChoAH et al.: Survey of differentially methylated promoters in prostate cancer cell lines.Neoplasia7(8) , 748–760 (2005).
  • Chen CM , ChenHL, HsiauTH et al.: Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.Am. J. Pathol.163(1) , 37–45 (2003).
  • Pike BL , GroshenS, HsuYH et al.: Comparisons of PCR-based genome amplification systems using CpG island microarrays.Hum. Mutat.27(6) , 589–596 (2006).
  • Smiraglia DJ , PlassC: The study of aberrant methylation in cancer via restriction landmark genomic scanning.Oncogene21(35) , 5414–5426 (2002).
  • Liu TH , RavalA, ChenSS, MatkovicJJ, ByrdJC, PlassC: CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.Cancer Res.66(2) , 653–658 (2006).
  • Park J , BrenaRM, GruidlM et al.: CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis.Cancer Biomark.1(2–3) , 193–200 (2005).
  • Costello JF , FruhwaldMC, SmiragliaDJ et al.: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.Nat. Genet.24(2) , 132–138 (2000).
  • Yuan E , HaghighiF, WhiteS et al.: A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons.Cancer Res.66(7) , 3443–3451 (2006).
  • Kerkel K , SpadolaA, YuanE et al.: Genomic surveys by methylation-sensitive snp analysis identify sequence-dependent allele-specific DNA methylation.Nat. Genet.40(7) , 904–908 (2008).
  • Hellman A , ChessA: Gene body-specific methylation on the active x chromosome.Science315(5815) , 1141–1143 (2007).
  • Clark SJ , HarrisonJ, PaulCL, FrommerM: High sensitivity mapping of methylated cytosines.Nucleic Acids Res.22(15) , 2990–2997 (1994).
  • Gitan RS , ShiH, ChenCM, YanPS, HuangTH: Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.Genome Res.12(1) , 158–164 (2002).
  • Aihara T , TakatsukaY, ItohK et al.: Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer.Oncology64 , 124–130 (2003).
  • Adorjan P , DistlerJ, LipscherE et al.: Tumour class prediction and discovery by microarray-based DNA methylation analysis.Nucleic Acids Res.30(5) , E21 (2002).
  • Shi H , MaierS, NimmrichI et al.: Oligonucleotide-based microarray for DNA methylation analysis: principles and applications.J. Cell Biochem.88(1) , 138–143 (2003).
  • Kimura N , NagasakaT, MurakamiJ et al.: Methylation profiles of genes utilizing newly developed CpG island methylation microarray on colorectal cancer patients.Nucleic Acids Res.33(5) , E46 (2005).
  • Bibikova M , LinZ, ZhouL et al.: High-throughput DNA methylation profiling using universal bead arrays.Genome Res.16(3) , 383–393 (2006).
  • Fazzari MJ , GreallyJM: Epigenomics: beyond CpG islands.Nat. Rev. Genet.5(6) , 446–455 (2004).
  • Keshet I , SchlesingerY, FarkashS et al.: Evidence for an instructive mechanism of de novo methylation in cancer cells.Nat. Genet.38(2) , 149–153 (2006).
  • Rauch T , LiH, WuX, PfeiferGP: Mira-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells.Cancer Res.66(16) , 7939–7947 (2006).
  • Shiraishi M , SekiguchiA, TerryMJ et al.: A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes.Oncogene21(23) , 3804–3813 (2002).
  • Gebhard C , SchwarzfischerL, PhamTH et al.: Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.Cancer Res.66(12) , 6118–6128 (2006).
  • Ballestar E , PazMF, ValleL et al.: Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.EMBO J.22(23) , 6335–6345 (2003).
  • Down TA , RakyanVK, TurnerDJ et al.: A bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis.Nat. Biotechnol.26(7) , 779–785 (2008).
  • Pelizzola M , KogaY, UrbanAE et al.: Medme: An experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment.Genome Res.18(10) , 1652–1659 (2008).
  • Ansorge WJ : Next-generation DNA sequencing techniques.N. Biotechnol.25(4) , 195–203 (2009).
  • Shendure JA , PorrecaGJ, ChurchGM: Overview of DNA sequencing strategies.Curr. Protoc. Mol. Biol. Chapter 7, Unit 7 1 (2008).
  • Cokus SJ , FengS, ZhangX et al.: Shotgun bisulphite sequencing of the arabidopsis genome reveals DNA methylation patterning.Nature452(7184) , 215–219 (2008).
  • Taylor KH , KramerRS, DavisJW et al.: Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.Cancer Res.67(18) , 8511–8518 (2007).
  • Meissner A , MikkelsenTS, GuH et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells.Nature454(7205) , 766–770 (2008).
  • Birney E , StamatoyannopoulosJA, DuttaA et al.: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.Nature447(7146) , 799–816 (2007).
  • Ball MP , LiJB, GaoY et al.: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells.Nat. Biotechnol.27(4) , 361–368 (2009).
  • Deng J , ShoemakerR, XieB et al.: Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming.Nat. Biotechnol.27(4) , 353–360 (2009).
  • Suzuki H , GabrielsonE, ChenW et al.: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.Nat. Genet.31(2) , 141–149 (2002).
  • Smiraglia DJ , RushLJ, FruhwaldMC et al.: Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies.Hum. Mol. Genet.10(13) , 1413–1419 (2001).
  • Melnikov AA , ScholtensDM, WileyEL, KhanSA, LevensonVV: Array-based multiplex analysis of DNA methylation in breast cancer tissues.J. Mol. Diagn.10(1) , 93–101 (2008).
  • Herman JG , GraffJR, MyohanenS, NelkinBD, BaylinSB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proc. Natl Acad. Sci. USA93(18) , 9821–9826 (1996).
  • To KF , LeungWK, LeeTL et al.: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.Int. J. Cancer102(6) , 623–628 (2002).
  • Shen L , CatalanoPJ, BensonAB 3rd, O‘Dwyer P, Hamilton SR, Issa JP: Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin.Cancer Res.13(20) , 6093–6098 (2007).
  • Cottrell SE , LairdPW: Sensitive detection of DNA methylation.Ann. NY Acad. Sci.983 , 120–130 (2003).
  • Eads CA , DanenbergKD, KawakamiK et al.: Methylight: a high-throughput assay to measure DNA methylation.Nucleic Acids Res.28(8) , E32 (2000).
  • Kagan J , SrivastavaS, BarkerPE, BelinskySA, CairnsP: Towards clinical application of methylated DNA sequences as cancer biomarkers: a joint NCI‘s EDRN and NIST workshop on standards, methods, assays, reagents and tools.Cancer Res.67(10) , 4545–4549 (2007).
  • Ehrich M , NelsonMR, StanssensP et al.: Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.Proc. Natl Acad. Sci. USA102(44) , 15785–15790 (2005).
  • Ehrich M , FieldJK, LiloglouT et al.: Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.Cancer Res.66(22) , 10911–10918 (2006).
  • Lin H -JL, Zuo T, Lin C-H et al.: Breast cancer-associated fibroblasts confer akt1-mediated epigenetic silencing of cystatin m in epithelial cells. Cancer Res.68(24) , 10257–10266 (2008).
  • Jones P , MartienssenR: A blueprint for a human epigenome project: the AACR human epigenome workshop.Cancer Res.65 , 11241–11246 (2005).
  • American Association for Cancer Research Human Epigenome Task Force; European Union, Network of Excellence, Scientific Advisory Board: Moving ahead with an international human epigenome project. Nature 454(7205) , 711–715 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.